Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The test compound has a low potential for causing human sensitizaiton. No reaction was noted in either the induced or control groups when challenged

Justification for classification or non-classification

Dimethyl 1,4 -cyclohexanecarboxylate (DMCD) is not currently classified for Skin Sensitization according to Annex I of Directive 67/548/EEC.  Based on a read-across assessment of the related compound, cyclohexanedicarboxylate (CHDA), dimethyl-1,4 -cyclohexanedicarboxylate (DMCD) is not classified for Skin Sensitization according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 and UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS).